Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan J Schauer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|November 5, 2019
Advances in Discovering Deubiquitinating Enzyme (DUB) InhibitorsNathan J Schauer, Robert S Magin, Xiaoxi Liu, et al.
Cell Chemical Biology|October 2, 2020
Proteomics-Based Identification of DUB Substrates Using Selective InhibitorsJonathan W Bushman, Katherine A Donovan, Nathan J Schauer, et al.
Cell Chemical Biology|October 24, 2017
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Xiaoxi Liu, Hyuk-Soo Seo, et al.
The Journal of Experimental Medicine|July 27, 2018
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcomaBjörn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, et al.
Leukemia|July 30, 2021
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2Jing Yang, Ellen L Weisberg, Xiaoxi Liu, et al.
Nature Communications|February 8, 2023
Accelerating inhibitor discovery for deubiquitinating enzymesWai Cheung Chan, Xiaoxi Liu, Robert S Magin, et al.
Cell Metabolism|February 26, 2019
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione DepletionIsaac S Harris, Jennifer E Endress, Jonathan L Coloff, et al.
Nature Chemical Biology|October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
Scientific Reports|March 27, 2020
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanismNathan J Schauer, Xiaoxi Liu, Robert S Magin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|November 5, 2019
Advances in Discovering Deubiquitinating Enzyme (DUB) InhibitorsNathan J Schauer, Robert S Magin, Xiaoxi Liu, et al.
Cell Chemical Biology|October 2, 2020
Proteomics-Based Identification of DUB Substrates Using Selective InhibitorsJonathan W Bushman, Katherine A Donovan, Nathan J Schauer, et al.
Cell Chemical Biology|October 24, 2017
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Xiaoxi Liu, Hyuk-Soo Seo, et al.
The Journal of Experimental Medicine|July 27, 2018
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcomaBjörn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, et al.
Leukemia|July 30, 2021
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2Jing Yang, Ellen L Weisberg, Xiaoxi Liu, et al.
Nature Communications|February 8, 2023
Accelerating inhibitor discovery for deubiquitinating enzymesWai Cheung Chan, Xiaoxi Liu, Robert S Magin, et al.
Cell Metabolism|February 26, 2019
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione DepletionIsaac S Harris, Jennifer E Endress, Jonathan L Coloff, et al.
Nature Chemical Biology|October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
Scientific Reports|March 27, 2020
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanismNathan J Schauer, Xiaoxi Liu, Robert S Magin, et al.
Pageof 1